Risks and benefits of breast cancer screening: BreastScreen WA cohort study of overdiagnosis and breast cancer mortality [ 2014 - 2017 ]

Research Grant

Researchers: Prof Dallas English (Principal investigator) ,  Dr Carolyn Nickson ,  Prof Anne Kavanagh ,  Prof David Roder

Brief description Overdiagnosis is the major downside of screening for breast cancer. This occurs when screening detects cancers that would not have caused symptoms in the woman's lifetime. This study aims to quantify the amount of overdiagnosis that occurs in the Australian breast cancer screening program (BreastScreen)

Funding Amount $AUD 201,524.34

Funding Scheme Project Grants

Notes Standard Project Grant